Chemical Engineering @ChemengFiles.Com

Elsevier has announced that it begins to provide consistent guidelines for their internal divisions of pharmaceutical services in reprints of products, collections of articles or advertising on behalf of pharmaceutical companies. This initiative follows the internal review began when the company experienced a series of publications produced in Australia between 2000 and 2005 that had the name "journal of" but that it lacked adequate sponsorship presentations and

Given the numbers identified in the series of Australasia, the company has acted to ensure that all of its pharmaceutical services division of the world continue the practice of patronage and have consistent standards for the products of several reprint articles. Although these divisions of pharmaceutical services frequently reprinted articles revised Elsevier, manage separate from the division that publishes the central collection of the company of major research publications.

Elsevier will review practices relating to all articles reprinted, collected or custom publications, establishing content guidelines, permit, use of re-printing and packaging to ensure that these publications do not mix with the revised central Elsevier publications and sponsorship of any publication is clearly presented. Elsevier hopes to complete its review and issue guidelines on June 30, 2009.

"The full presentation should be the standard of Elsevier, and we need to improve every day to make sure that we strengthen the consistent global guidelines for sponsorship and product presentation reprint articles", indicóMichael Hansen, CEO of Elsevier Health Sciences. "I want to assure our authors, editors and customers that the integrity of our research publications have been revised not compromised in any way. These guidelines will help ensure that there is no confusion between these special collections, and our main central collection of publications research.